Zhongshan Laibo Ruichen Biomedicine Co., Ltd.

Phase II Clinical Trial of RAB001 Officially Launched at Peking University Third Hospital!

First Subject Enrolled in Phase II Clinical Trial of World's First Osteonecrosis Drug RAB001!

Rabpharma Wins Silver Award at Greater Bay Area Postdoctoral Innovation Competition!

Groundbreaking: Rabpharma Officially Launches Phase II Clinical Trial of RAB001 at Shanghai Sixth People's Hospital!

Rabpharma Wins "Outstanding Enterprise Award" at National Finals of China Innovation & Entrepreneurship Competition!